Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority.
作者信息
Harlow Alyssa F, Leventhal Adam M, Barrington-Trimis Jessica L
机构信息
Department of Population and Public Health Sciences and Institute for Addiction Science, Keck School of Medicine, University of Southern California, Los Angeles.
出版信息
JAMA. 2022 Nov 22;328(20):2007-2008. doi: 10.1001/jama.2022.20620.
Abstract
摘要
相似文献
1
Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority.堵住大麻衍生产品的漏洞：一项公共卫生优先事项。
JAMA. 2022 Nov 22;328(20):2007-2008. doi: 10.1001/jama.2022.20620.
2
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.大麻（ marijuana ）和大麻二酚（ CBD ）在美国法律下的法律地位。
Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4.
3
Public Health Implications of Cannabis Legalization: An Exploration of Adolescent Use and Evidence-Based Interventions.大麻合法化对公共卫生的影响：青少年使用情况及循证干预措施探究
Int J Environ Res Public Health. 2022 Mar 11;19(6):3336. doi: 10.3390/ijerph19063336.
4
Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products?Delta-8、Delta-10、HHC、THC-O、THCP 和 THCV：我们应该如何称呼这些产品？
J Stud Alcohol Drugs. 2023 May;84(3):357-360. doi: 10.15288/jsad.23-00008. Epub 2023 Mar 14.
5
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.合法与非法娱乐用大麻市场中大麻使用的流行情况及形式。
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.
6
Impact of cannabis-infused edibles on public safety and regulation.含大麻素的可食用产品对公共安全和监管的影响。
J Forensic Sci. 2022 Nov;67(6):2387-2393. doi: 10.1111/1556-4029.15135. Epub 2022 Sep 12.
7
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.美国和加拿大医用大麻使用的流行情况和自我报告原因。
Psychopharmacology (Berl). 2022 May;239(5):1509-1519. doi: 10.1007/s00213-021-06047-8. Epub 2022 Jan 12.
8
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.医用大麻患者将大麻用于娱乐目的的流行情况和相关因素。
Addict Behav. 2019 Jun;93:233-239. doi: 10.1016/j.addbeh.2019.02.003. Epub 2019 Feb 7.
9
Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016-2019.2016-2019 年美国国家毒物中心数据显示：合成大麻素中毒与合法大麻市场准入的关联。
Clin Toxicol (Phila). 2022 Sep;60(9):1024-1028. doi: 10.1080/15563650.2022.2099887. Epub 2022 Aug 8.
10
Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020.美国休闲大麻法律是否与医疗大麻项目注册人数下降有关？对 2013 年至 2020 年持卡人注册和人口统计特征的分析。
Int J Drug Policy. 2022 Feb;100:103531. doi: 10.1016/j.drugpo.2021.103531. Epub 2021 Nov 21.
引用本文的文献
1
Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial.健康成年人中大麻二酚与肝酶水平升高：一项随机临床试验。
JAMA Intern Med. 2025 Jul 7. doi: 10.1001/jamainternmed.2025.2366.
2
Impact of Delta-8-THC warning labels on perceived intoxication, harm, and susceptibility among adolescents.δ-8-四氢大麻酚警示标签对青少年感知到的醉酒程度、危害及易感性的影响。
Int J Drug Policy. 2025 May;139:104781. doi: 10.1016/j.drugpo.2025.104781. Epub 2025 Apr 4.
3
Association between cannabis use and nicotine use persistence among adolescents.青少年时期大麻使用与尼古丁使用持续存在之间的关联。
Addict Behav. 2024 Nov;158:108106. doi: 10.1016/j.addbeh.2024.108106. Epub 2024 Jul 19.
4
State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022.2017年至2022年美国老年人的州级大麻合法化与大麻相关疾病趋势
JAMA Netw Open. 2024 Jun 3;7(6):e2417634. doi: 10.1001/jamanetworkopen.2024.17634.
5
Adolescent Δ8-THC and Marijuana Use in the US.美国青少年使用Δ8-四氢大麻酚和大麻的情况。
JAMA. 2024 Mar 12;331(10):861-865. doi: 10.1001/jama.2024.0865.
6
Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis.基于 Transformer 的主题建模在研究 δ-8 四氢大麻酚讨论中的应用：内容分析。
J Med Internet Res. 2023 Dec 21;25:e49469. doi: 10.2196/49469.
7
Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.美国青少年吸食大麻素电子烟的流行情况及相关因素分析。
JAMA Netw Open. 2023 Aug 1;6(8):e2329167. doi: 10.1001/jamanetworkopen.2023.29167.
8
Self-reported adverse events associated with ∆-Tetrahydrocannabinol (Delta-8-THC) Use.与使用∆-四氢大麻酚（Delta-8-THC）相关的自我报告不良事件。
J Cannabis Res. 2023 May 23;5(1):15. doi: 10.1186/s42238-023-00191-y.
9
Novel methods for the remote investigation of emerging substances: Application to kratom.新兴物质的远程调查新方法：在恰特草中的应用。
Exp Clin Psychopharmacol. 2024 Apr;32(2):215-227. doi: 10.1037/pha0000656. Epub 2023 May 22.
10
Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013-2020.2013 年至 2020 年期间，美国居民出于医疗目的使用大麻的比例不断增加。
Am J Prev Med. 2023 Sep;65(3):528-533. doi: 10.1016/j.amepre.2023.03.005. Epub 2023 Mar 12.
本文引用的文献
1
5 Things to Know About Delta-8 Tetrahydrocannabinol: Delta-8 THC.关于δ-8四氢大麻酚（Delta-8 THC）需要了解的五件事
Mo Med. 2022 Jan-Feb;119(1):21-22.
2
The Hemp Loophole: A Need to Clarify the Legality of Delta-8-THC and Other Hemp-Derived Tetrahydrocannabinol Compounds.大麻漏洞：需要厘清δ-8-四氢大麻酚及其他大麻衍生的四氢大麻酚化合物的合法性
Am J Public Health. 2021 Nov;111(11):1927-1931. doi: 10.2105/AJPH.2021.306499. Epub 2021 Oct 7.
3
The EVALI outbreak and vaping in the COVID-19 era.新冠疫情时代的电子烟或雾化产品使用相关肺损伤（EVALI）疫情与电子烟使用情况
Lancet Respir Med. 2020 Sep;8(9):831. doi: 10.1016/S2213-2600(20)30360-X. Epub 2020 Aug 14.
Zotero 插件